Pharvaris Net Worth
Pharvaris Net Worth Breakdown | PHVS |
Pharvaris Net Worth Analysis
Pharvaris' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Pharvaris' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Pharvaris' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Pharvaris' net worth analysis. One common approach is to calculate Pharvaris' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Pharvaris' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Pharvaris' net worth. This approach calculates the present value of Pharvaris' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Pharvaris' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Pharvaris' net worth. This involves comparing Pharvaris' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Pharvaris' net worth relative to its peers.
Enterprise Value |
|
To determine if Pharvaris is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Pharvaris' net worth research are outlined below:
| Pharvaris BV appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (99.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pharvaris BV currently holds about 201.38 M in cash with (93.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96. | |
| Pharvaris BV has a frail financial position based on the latest SEC disclosures | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Pharvaris reports Q3 results |
Pharvaris uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Pharvaris BV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pharvaris' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Pharvaris' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.21 B.Market Cap |
|
Project Pharvaris' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.26) | (0.28) |
When accessing Pharvaris' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Pharvaris' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Pharvaris' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Pharvaris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharvaris BV. Check Pharvaris' Beneish M Score to see the likelihood of Pharvaris' management manipulating its earnings.
Evaluate Pharvaris' management efficiency
Pharvaris BV has return on total asset (ROA) of (0.2679) % which means that it has lost $0.2679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4505) %, meaning that it created substantial loss on money invested by shareholders. Pharvaris' management efficiency ratios could be used to measure how well Pharvaris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.27 in 2024. Return On Capital Employed is likely to drop to -0.26 in 2024. At this time, Pharvaris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 885.3 K in 2024, whereas Return On Tangible Assets are likely to drop (0.27) in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 10.00 | 10.50 | |
| Tangible Book Value Per Share | 10.00 | 10.50 | |
| Enterprise Value Over EBITDA | (6.02) | (6.32) | |
| Price Book Value Ratio | 2.54 | 2.41 | |
| Enterprise Value Multiple | (6.02) | (6.32) | |
| Price Fair Value | 2.54 | 2.41 | |
| Enterprise Value | 583.2 M | 522.7 M |
The leadership approach at Pharvaris' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Return On Equity (0.45) |
Pharvaris Corporate Filings
6K | 13th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 12th of April 2024 Other Reports | ViewVerify | |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Pharvaris Earnings per Share Projection vs Actual
Pharvaris Corporate Management
| Peng MD | Chief Officer | Profile | |
| Morgan Conn | Chief Officer | Profile | |
| Jochen Knolle | Chief COO | Profile | |
| CPA MBA | CEO CoFounder | Profile | |
| Joan JD | Chief Officer | Profile | |
| Stefan Abele | Chief Officer | Profile | |
| Wim Souverijns | Chief Officer | Profile |
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.